{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:00:44Z","timestamp":1777402844706,"version":"3.51.4"},"reference-count":126,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Immune dysregulation is being increasingly recognized as a prominent feature of a wide range inborn errors of immunity (IEIs) with different molecular backgrounds. Among the manifestations of immune dysregulation, inflammatory arthritis has emerged as an important yet underrecognized complication that may occur across multiple IEI categories, including humoral immunodeficiencies (such as X-linked agammaglobulinemia, hyper-IgM syndrome, common variable immunodeficiency, and others), complement deficiencies, disorders of immune dysregulation (STAT3 gain of function mutation, CTLA4 and LRBA haploinsufficiency), and combined immunodeficiencies. In some patients, arthritis may represent the first or predominant clinical manifestation, resulting in a diagnostic challenge in the rheumatologic setting. The pathogenesis of arthritis in IEIs reflects different immunological mechanisms, including the defective clearance of immune complexes, dysregulated B- and T-cell responses, impaired regulatory T-cell function, and aberrant cytokine signaling. Clinically, IEI-associated arthritis may mimic classical rheumatologic conditions such as juvenile idiopathic arthritis, rheumatoid arthritis, or other connective tissue diseases, although distinctive immunological and histopathological features are often present. Recognizing arthritis as a potential manifestation of IEIs has important clinical implications. The presence of specific \u201cred flags\u201d, including treatment refractoriness, recurrent infections, or additional signs of immune dysregulation (other autoimmune diseases, atopy, lymphoproliferation, enteropathy), should prompt targeted immunological evaluation. While management often relies on conventional immunosuppressive therapies, advances in the molecular characterization of IEIs are increasingly enabling the use of targeted treatments directed at the underlying pathogenic mechanisms. This paper provides an overview of the current knowledge of arthritis associated with IEIs, highlighting diagnostic challenges, underlying immunopathogenic mechanisms, and emerging therapeutic perspectives.<\/jats:p>","DOI":"10.3390\/jcm15093298","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:55:39Z","timestamp":1777370139000},"page":"3298","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Intertwining Between Arthritis and Inborn Errors of Immunity"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-1945","authenticated-orcid":false,"given":"Rita","family":"Consolini","sequence":"first","affiliation":[{"name":"Section of Clinical and Laboratory Immunology, Pediatric Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Maestrini","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6615-4788","authenticated-orcid":false,"given":"Sarah","family":"Abu-Rumeileh","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Costagliola","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Azienda Ospedaliero-Universitaria Pisana, 56100 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e20250003","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J. Hum. Immun."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Costagliola, G., Peroni, D.G., and Consolini, R. (2022). Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.855445"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pai.13632","article-title":"Congenital and acquired defects of immunity: An ever-evolving story","volume":"33","author":"Castagnoli","year":"2022","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13223-024-00938-z","article-title":"Inborn errors of immunity (primary immunodeficiencies)","volume":"20","author":"Kim","year":"2025","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","article-title":"Autoimmunity and primary immunodeficiency: Two sides of the same coin?","volume":"14","author":"Schmidt","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaci.2023.11.005","article-title":"Hypogammaglobulinemia and immune dysregulation-not just 2 sides of a coin","volume":"153","author":"Uzel","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104501","DOI":"10.1016\/j.ebiom.2023.104501","article-title":"The link between rheumatic disorders and inborn errors of immunity","volume":"90","author":"Sogkas","year":"2023","journal-title":"EBioMedicine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Costagliola, G., Cappelli, S., and Consolini, R. (2021). Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204729"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10067-016-3229-6","article-title":"Rheumatologic manifestations of primary immunodeficiency diseases","volume":"35","author":"Dimitriades","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","article-title":"Juvenile idiopathic arthritis: From aetiopathogenesis to therapeutic approaches","volume":"19","author":"Zaripova","year":"2021","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_13","first-page":"e30330","article-title":"An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/annrheumdis-2020-218280","article-title":"High frequency of variants in genes associated with primary immunodeficiencies in patients with rheumatic diseases with secondary hypogammaglobulinaemia","volume":"80","author":"Sogkas","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00281-022-00912-0","article-title":"Genetics of rheumatoid arthritis","volume":"44","author":"Padyukov","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/art.40216","article-title":"Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci","volume":"69","author":"McIntosh","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","article-title":"Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: Clinical and therapeutic implications","volume":"76","author":"Ombrello","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","first-page":"S250","article-title":"Unique susceptibility of patients with antibody deficiency to mycoplasma infection","volume":"17","author":"Gelfand","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s15010-024-02301-1","article-title":"Disseminated septic arthritis caused by Ureaplasma urealyticum in an immunocompromised patient with hypogammaglobulinemia after rituximab therapy","volume":"52","author":"Oguni","year":"2024","journal-title":"Infection"},{"key":"ref_20","first-page":"708","article-title":"Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis","volume":"28","author":"Elsby","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41423-020-00626-z","article-title":"Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity","volume":"18","author":"Sogkas","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Saeidi, Z., Fadai, S., Mesdaghi, M., Mirzaee, A.Z., Sharafian, S., Rahmani, K., Eslami, N., Parvaneh, V.J., Talebi, M., and Chavoshzadeh, Z. (2025). Rheumatologic manifestations in children with underlying inborn errors of immunity. BMC Rheumatol., 9.","DOI":"10.1186\/s41927-025-00508-9"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Elsink, K., Huibers, M.M.H., Hollink, I.H.I.M., Simons, A., Zonneveld-Huijssoon, E., van der Veken, L.T., Leavis, H.L., Henriet, S.S.V., van Deuren, M., and van de Veerdonk, F.L. (2021). Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic Centers. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.780134"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000519199","article-title":"Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency","volume":"183","author":"Sogkas","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.semarthrit.2018.02.013","article-title":"Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency","volume":"48","author":"Gutierrez","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.13600","article-title":"Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: A systematic review","volume":"205","author":"Jamee","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review","volume":"7","author":"Fabre","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"103271","DOI":"10.1016\/j.eclinm.2025.103271","article-title":"Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: An observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET)","volume":"84","author":"Soresina","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Catucci, M., Castiello, M.C., Pala, F., Bosticardo, M., and Villa, A. (2012). Autoimmunity in wiskott-Aldrich syndrome: An unsolved enigma. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00209"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.waojou.2019.100018","article-title":"X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world","volume":"12","author":"Abramova","year":"2019","journal-title":"World Allergy Organ. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10875-023-01633-1","article-title":"Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency","volume":"44","author":"Banday","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/pai.13535","article-title":"Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review","volume":"32","author":"Hafezi","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e12663","DOI":"10.1111\/sji.12663","article-title":"Rheumatologic complications in a cohort of 227 patients with common variable immunodeficiency","volume":"87","author":"Azizi","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12016-019-08756-7","article-title":"The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency","volume":"58","author":"Odineal","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ard.2004.030049","article-title":"X linked agammaglobulinaemia and rheumatoid arthritis","volume":"64","author":"Verbruggen","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-018-0574-z","article-title":"Autoimmunity and Inflammation in CVID: A Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications","volume":"39","author":"Fevang","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41390-019-0600-8","article-title":"Rheumatological manifestations in inborn errors of immunity","volume":"87","author":"Pazmandi","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cellimm.2016.12.007","article-title":"Abnormality of regulatory T cells in common variable immunodeficiency","volume":"315","author":"Azizi","year":"2017","journal-title":"Cell. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.autrev.2014.04.006","article-title":"Common variable immunodeficiency and autoimmunity--an inconvenient truth","volume":"13","author":"Xiao","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jbspin.2004.07.012","article-title":"Bone and joint disease associated with primary immune deficiencies","volume":"72","author":"Sordet","year":"2005","journal-title":"Jt. Bone Spine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bmj.295.6591.174","article-title":"Primary hypogammaglobulinaemia and arthritis","volume":"295","author":"Hansel","year":"1987","journal-title":"Br. Med. J."},{"key":"ref_44","first-page":"22","article-title":"Agammaglobulinemia: From X-linked to Autosomal Forms of Disease","volume":"63","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11882-013-0350-3","article-title":"Autoimmunity in immunodeficiency","volume":"13","author":"Todoric","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2009.03.003","article-title":"X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity","volume":"33","author":"Pessach","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000453263","article-title":"Autoimmunity in Primary Antibody Deficiencies","volume":"171","author":"Azizi","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","article-title":"The health status and quality of life of adults with X-linked agammaglobulinemia","volume":"118","author":"Howard","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10875-014-0056-x","article-title":"Autoimmunity and inflammation in X-linked agammaglobulinemia","volume":"34","author":"Scalchunes","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"ref_50","first-page":"1407","article-title":"The prevalence and meaning of fatigue in rheumatic disease","volume":"23","author":"Wolfe","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/03009742.2014.995699","article-title":"X-linked agammaglobulinemia in two siblings with a novel mutation in the BTK gene who presented with polyarticular juvenile idiopathic arthritis","volume":"44","author":"Patiroglu","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12016-017-8645-0","article-title":"Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome Sequencing","volume":"54","author":"Ameratunga","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1078\/0171-2985-00198","article-title":"Expansion of CD19(hi)CD21(lo\/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia","volume":"206","author":"Warnatz","year":"2002","journal-title":"Immunobiology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1159\/000508817","article-title":"Monogenic Primary Immunodeficiency Disorder Associated with Common Variable Immunodeficiency and Autoimmunity","volume":"181","author":"Asgardoon","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-018-0941-0","article-title":"The burden of common variable immunodeficiency disorders: A retrospective analysis of the European Society for Immunodeficiency (ESID) registry data","volume":"13","author":"Odnoletkova","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: Clinical and immunological features of 248 patients","volume":"92","author":"Bodian","year":"1999","journal-title":"Clin. Immunol."},{"key":"ref_57","first-page":"323","article-title":"Autoimmune phenotype in patients with common variable immunodeficiency","volume":"23","author":"Abolhassani","year":"2013","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): Common Variable Immunodeficiency Disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chawla, S., Barman, P., Tyagi, R., Jindal, A.K., Sharma, S., Rawat, A., and Singh, S. (2022). Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.869466"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/1744666X.2021.1850272","article-title":"Autoimmunity in common variable immunodeficiency: A systematic review and meta-analysis","volume":"16","author":"Rizvi","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/sji.12499","article-title":"Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management","volume":"85","author":"Yazdani","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"ref_63","first-page":"112","article-title":"Autoimmunity in patients with selective IgA deficiency","volume":"25","author":"Abolhassani","year":"2015","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1744666X.2016.1224664","article-title":"Autoimmunity in common variable immunodeficiency: Epidemiology, pathophysiology and management","volume":"13","author":"Azizi","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Lemarquis, A.L., Sigurgrimsdottir, H., Theodors, F.P., Karnsund, I., Einarsdottir, H.K., Jorgensen, G., Ekwall, O., Jonsdottir, I., and Ludviksson, B.R. (2026). Serologic IL-18 increase with B-cell IL-18R loss characterizes selective IgA deficiency. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1687720"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ard.62.1.83","article-title":"Abnormal IgA levels in patients with rheumatoid arthritis","volume":"62","author":"Badcock","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10875-014-0009-4","article-title":"Association between IgA deficiency & other autoimmune conditions: A population-based matched cohort study","volume":"34","author":"Ludvigsson","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ACI.0b013e3283594219","article-title":"IgA deficiency: What is new?","volume":"12","author":"Wang","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1086\/302326","article-title":"Genetic linkage of IgA deficiency to the major histocompatibility complex: Evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition","volume":"64","author":"Webster","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/1744666X.2017.1248410","article-title":"The long and winding road to IgA deficiency: Causes and consequences","volume":"13","author":"Krist","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lemarquis, A.L., Einarsdottir, H.K., Kristjansdottir, R.N., Jonsdottir, I., and Ludviksson, B.R. (2018). Transitional B Cells and TLR9 Responses Are Defective in Selective IgA Deficiency. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00909"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lemarquis, A.L., Theodors, F., Einarsdottir, H.K., and Ludviksson, B.R. (2019). Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00403"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E1399","DOI":"10.1073\/pnas.1107830108","article-title":"The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells","volume":"108","author":"Enoksson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1016\/j.jtauto.2019.100025","article-title":"The clinical implications of selective IgA deficiency","volume":"2","author":"Swain","year":"2019","journal-title":"J. Transl. Autoimmun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01142.x","article-title":"X-linked immunodeficiency with hyper-IgM (XHIM)","volume":"120","author":"Notarangelo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2018.11.007","article-title":"The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management","volume":"198","author":"Yazdani","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10875-008-9171-x","article-title":"Autoimmunity in hyper-IgM syndrome","volume":"28","author":"Jesus","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: Clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)81349-5","article-title":"Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor","volume":"87","author":"Rathmell","year":"1996","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.20062287","article-title":"CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance","volume":"204","author":"Isnardi","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J. Pediatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/1529-0131(199906)42:6<1291::AID-ANR29>3.0.CO;2-#","article-title":"An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome)","volume":"42","author":"Webster","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"751","DOI":"10.52312\/jdrs.2025.1988","article-title":"Rare coexistence of X-linked hyper immunoglobulin M syndrome and polyarticular juvenile idiopathic arthritis in a Chinese child: A case report","volume":"36","author":"Li","year":"2025","journal-title":"Jt. Dis. Relat. Surg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-031-85340-1_7","article-title":"The Complement System","volume":"1476","author":"Revel","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"102979","DOI":"10.1016\/j.jaut.2022.102979","article-title":"The complement system and human autoimmune diseases","volume":"137","author":"Coss","year":"2023","journal-title":"J. Autoimmun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.42270","article-title":"Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway with Risk of Systemic Lupus Erythematosus and Primary Sj\u00f6gren\u2019s Syndrome","volume":"74","author":"Lundtoft","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2015.03.007","article-title":"Clinical presentation of human C1q deficiency: How much of a lupus?","volume":"67","author":"Stegert","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/RHU.0b013e318156b9e3","article-title":"Partial C4 deficiency in juvenile idiopathic arthritis patients","volume":"13","author":"Gilliam","year":"2007","journal-title":"J. Clin. Rheumatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/art.33472","article-title":"Increased frequency of complement C4B deficiency in rheumatoid arthritis","volume":"64","author":"Rigby","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/BOR.0000000000000633","article-title":"Complement, infection, and autoimmunity","volume":"31","author":"Conigliaro","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2023.11.021","article-title":"IPEX syndrome from diagnosis to cure, learning along the way","volume":"153","author":"Bacchetta","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2023.02.010","article-title":"A multifaceted disease: The stats of STAT3 GOF","volume":"151","author":"Freeman","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","article-title":"Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency","volume":"152","author":"Taghizade","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cei.13620","article-title":"Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge","volume":"205","author":"Costagliola","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40348-023-00167-1","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: Breakdown of immune homeostasis and immune dysregulation","volume":"10","author":"Toskov","year":"2023","journal-title":"Mol. Cell. Pediatr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00277-022-04761-7","article-title":"ALPS, FAS, and beyond: From inborn errors of immunity to acquired immunodeficiencies","volume":"101","author":"Consonni","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/rheumatology\/keab361","article-title":"The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory\/autoimmune disorders","volume":"61","author":"Terranova","year":"2022","journal-title":"Rheumatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaci.2023.11.004","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders","volume":"153","author":"Magerus","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2023.06.015","article-title":"Activated phosphoinositide 3-kinase \u03b4 syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity","volume":"152","author":"Maccari","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","article-title":"Clinical, Immunological, and Genetic Features in Patients with Activated PI3K\u03b4 Syndrome (APDS): A Systematic Review","volume":"59","author":"Jamee","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10875-024-01835-1","article-title":"Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase \u03b4 Syndrome in the Target Therapy Era","volume":"45","author":"Barzaghi","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Albert, M.H., and Freeman, A.F. (2019). Wiskott-Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8- (DOCK8) Deficiency. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00451"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/bjh.15831","article-title":"How I manage patients with Wiskott Aldrich syndrome","volume":"185","author":"Rivers","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.2024026288","article-title":"How I treat Wiskott-Aldrich syndrome","volume":"146","author":"Albert","year":"2025","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/TACG.S213920","article-title":"Autoimmunity in Wiskott-Aldrich Syndrome: Updated Perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott-Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J. Pediatr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.111.5.e622","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: Risk factors, clinical features, and outcome in a single-center cohort of 55 patients","volume":"111","author":"Medioni","year":"2003","journal-title":"Pediatrics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13023-025-04088-2","article-title":"Chronic inflammatory arthritis in 22q11.2 deletion (DiGeorge) syndrome: A multicentric study","volume":"20","author":"Liebling","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-019-0854-5","article-title":"Novel Developments in Primary Immunodeficiencies (PID)-a Rheumatological Perspective","volume":"21","author":"Leavis","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.autrev.2016.07.011","article-title":"Autoimmunity and infection in common variable immunodeficiency (CVID)","volume":"15","author":"Patuzzo","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: Defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-020-00854-y","article-title":"USIDNET Consortium. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and\/or Related TBX1 Mutations): A USIDNET Study","volume":"41","author":"Deshpande","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaci.2021.06.007","article-title":"Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases","volume":"149","author":"Crowley","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jaip.2019.03.014","article-title":"Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome","volume":"7","author":"Montin","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.2018885244","article-title":"Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center","volume":"133","author":"Giardino","year":"2019","journal-title":"Blood"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Costagliola, G., Legitimo, A., Bertini, V., Alberio, A.M.Q., Valetto, A., and Consolini, R. (2023). Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious Phenotype. J. Clin. Med., 12.","DOI":"10.3390\/jcm12247579"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e20250034","DOI":"10.70962\/jhi.20250034","article-title":"Rheumatologic and Autoimmune Features of Inborn Errors of Immunity: Implications for Diagnosis and Management","volume":"1","author":"Tobin","year":"2025","journal-title":"J. Hum. Immun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"D\u0105browska, A., Grze\u015bk, E., Urba\u0144czyk, A., Mazalon, M., Grze\u015bk, G., Styczy\u0144ski, J., and Ko\u0142tan, S. (2023). Extended List of Warning Signs in Qualification to Diagnosis and Treatment of Inborn Errors of Immunity in Children and Young Adults. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103401"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ameratunga, R., Brewerton, M., Slade, C., Jordan, A., Gillis, D., Steele, R., Koopmans, W., and Woon, S.T. (2014). Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00415"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Accardo, V., Pagnini, I., Maccora, I., Marrani, E., Mastrolia, M.V., and Simonini, G. (2024). Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity. Front. Pediatr., 12.","DOI":"10.3389\/fped.2024.1353825"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Delmonte, O.M., Castagnoli, R., Calzoni, E., and Notarangelo, L.D. (2019). Inborn Errors of Immunity with Immune Dysregulation: From Bench to Bedside. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00353"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","article-title":"JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition","volume":"148","author":"Luo","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaci.2023.09.032","article-title":"Interim analysis: Open-label extension study of leniolisib for patients with APDS","volume":"153","author":"Rao","year":"2024","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3298\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:25:57Z","timestamp":1777371957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":126,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15093298"],"URL":"https:\/\/doi.org\/10.3390\/jcm15093298","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]}}}